Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Roth

Showing results (301-310 of 410) with videos related to

Pageof 41
Sort By:
Neuroscience|June 1, 1992
Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systemsD L Rosin, W A Clark, M Goldstein, et al.
Experimental Neurology|June 1, 1993
Tyrosine hydroxylase immunoreactivity and monoamine and metabolite levels in cryopreserved human fetal ventral mesencephalonP J Kontur, C Leranth, D E Redmond, et al.
Cell Transplantation|May 1, 1997
Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donorsT Alexander, C E Sortwell, C D Sladek, et al.
European Journal of Pharmacology|February 24, 1987
Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal responseA Y Deutch, S Y Tam, A S Freeman, et al.
Neuroscience|October 8, 1997
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)J R Taylor, J D Elsworth, R H Roth, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: implications for schizophreniaJ D Jentsch, J D Elsworth, J R Taylor, et al.
Pharmacology, Biochemistry, and Behavior|May 31, 2011
Aged monkeys as a partial model for Parkinson's diseaseP J Hurley, J D Elsworth, M C Whittaker, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1980
Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidolM J Bannon, E B Bunney, J R Zigun, et al.
Psychopharmacology Communications|January 1, 1975
D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neuronsB S Bunney, J R Walters, M J Kuhar, et al.
Brain Research|August 9, 1991
Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptorsT W Lovenberg, D E Nichols, E J Nestler, et al.
Pageof 41

Showing results (301-310 of 410) with videos related to

Sort By:
Pageof 41
Neuroscience|June 1, 1992
Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systemsD L Rosin, W A Clark, M Goldstein, et al.
Experimental Neurology|June 1, 1993
Tyrosine hydroxylase immunoreactivity and monoamine and metabolite levels in cryopreserved human fetal ventral mesencephalonP J Kontur, C Leranth, D E Redmond, et al.
Cell Transplantation|May 1, 1997
Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donorsT Alexander, C E Sortwell, C D Sladek, et al.
European Journal of Pharmacology|February 24, 1987
Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal responseA Y Deutch, S Y Tam, A S Freeman, et al.
Neuroscience|October 8, 1997
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)J R Taylor, J D Elsworth, R H Roth, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: implications for schizophreniaJ D Jentsch, J D Elsworth, J R Taylor, et al.
Pharmacology, Biochemistry, and Behavior|May 31, 2011
Aged monkeys as a partial model for Parkinson's diseaseP J Hurley, J D Elsworth, M C Whittaker, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 1, 1980
Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidolM J Bannon, E B Bunney, J R Zigun, et al.
Psychopharmacology Communications|January 1, 1975
D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neuronsB S Bunney, J R Walters, M J Kuhar, et al.
Brain Research|August 9, 1991
Guanine nucleotide binding proteins and the regulation of cyclic AMP synthesis in NS20Y neuroblastoma cells: role of D1 dopamine and muscarinic receptorsT W Lovenberg, D E Nichols, E J Nestler, et al.
Pageof 41